Citius Pharmaceuticals Inc (NASDAQ:CTXR) price closed lower on Tuesday, May 07, dropping -1.89% below its previous close.
A look at the daily price movement shows that the last close reads $0.70. Taking into account the 52-week price action we note that the stock hit a 52-week high of $1.45 and 52-week low of $0.60. The stock subtracted -28.77% on its value in the past month.
Staying with the analyst view, there is a consensus estimate of 61.72M for the company’s annual revenue in current year.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give CTXR a short term outlook of 100% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a Hold, while an average of long term indicators are currently assigning the stock as 100% Sell.
The overview shows that CTXR’s price is at present -9.59% off the SMA20 and -12.73% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 40.68, with weekly volatility standing at 7.08%. The indicator jumps to 10.53% when calculated based on the past 30 days. Citius Pharmaceuticals Inc (NASDAQ:CTXR)’s beta value is holding at 1.64, while the average true range (ATR) indicator is currently reading 0.07.
An analysis of the Citius Pharmaceuticals Inc (NASDAQ:CTXR) stock in terms of its daily trading volume indicates that the 3-month average is 911.85K.
Current records show that the company has 180.52M in outstanding shares. The insiders’ percentage holdings are 7.74% of outstanding shares while the percentage share held by institutions stands at 15.00%. But the -9.52% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
